These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36065675)

  • 1. Comprehensive review of oral minoxidil in alopecia.
    Modha JD; Pathania YS
    J Cosmet Dermatol; 2022 Nov; 21(11):5527-5531. PubMed ID: 36065675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review.
    Sharma AN; Michelle L; Juhasz M; Muller Ramos P; Atanaskova Mesinkovska N
    Int J Dermatol; 2020 Aug; 59(8):1013-1019. PubMed ID: 32516434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral minoxidil treatment for hair loss: A review of efficacy and safety.
    Randolph M; Tosti A
    J Am Acad Dermatol; 2021 Mar; 84(3):737-746. PubMed ID: 32622136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?
    Singh S; Patil A; Kianfar N; Waśkiel-Burnat A; Rudnicka L; Sinclair R; Goldust M
    Clin Exp Dermatol; 2022 Nov; 47(11):1951-1955. PubMed ID: 35881665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
    Faghihi G; Iraji F; Siadat AH; Saber M; Jelvan M; Hoseyni MS
    J Cosmet Dermatol; 2022 Oct; 21(10):4447-4453. PubMed ID: 35152531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
    Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
    J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-Label Use of Topical Minoxidil in Alopecia: A Review.
    Stoehr JR; Choi JN; Colavincenzo M; Vanderweil S
    Am J Clin Dermatol; 2019 Apr; 20(2):237-250. PubMed ID: 30604379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose.
    Villani A; Fabbrocini G; Ocampo-Candiani J; Ruggiero A; Ocampo-Garza SS
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):1485-1492. PubMed ID: 33660357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
    Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
    Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical and oral minoxidil for hair disorders in pediatric patients: What do we know so far?
    Lemes LR; Melo DF; de Oliveira DS; de La-Rocque M; Zompero C; Ramos PM
    Dermatol Ther; 2020 Nov; 33(6):e13950. PubMed ID: 32614119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing combination low-dose oral minoxidil and topical minoxidil with oral minoxidil alone for the treatment of non-scarring alopecia: A retrospective chart review.
    Klein EJ; Karim M; Shapiro J; Sicco KL
    J Cosmet Dermatol; 2022 Nov; 21(11):6473-6475. PubMed ID: 35642572
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.
    Tsuboi R; Arano O; Nishikawa T; Yamada H; Katsuoka K
    J Dermatol; 2009 Aug; 36(8):437-46. PubMed ID: 19691748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minoxidil: a comprehensive review.
    Gupta AK; Talukder M; Venkataraman M; Bamimore MA
    J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of microneedling with 5% minoxidil topical solution combination therapy in treatment of androgenetic alopecia.
    Jia L; Xiong J; Guo R; Li Y; Jiang H
    J Cosmet Dermatol; 2022 Nov; 21(11):5665-5671. PubMed ID: 35861653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.